As disclosed above in Note 1, “Business Overview and Basis of Presentation”, all share and per share amounts have been adjusted to reflect the Reverse Stock Split for all periods presented.

The following table presents the share-based compensation expense by award type recognized within the following line items in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and Condensed Consolidated Balance Sheet in the periods presented:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Restricted stock units	$	19,982	$	24,375	$	39,208	$	47,909
Stock options	453		1,349		1,349		3,623
Performance restricted stock units	1,753		1,153		1,458		1,072
Employee Stock Purchase Plan	168		193		358		381

Share-based compensation recorded within Compensation and benefits	22,356		27,070		42,373		52,985

Property and equipment (capitalized internal-use software)	2,388		3,187		4,994		5,709
Total share-based compensation expense	$	24,744	$	30,257	$	47,367	$	58,694

A summary of the Company's restricted stock units (RSUs) and performance-based restricted stock units (PSUs) activity under the Plans was as follows:


	Number of Units	Weighted- average grant date fair value per share
Balance as of December 31, 2025	7,271	$	19.52
Granted	6,460	$	15.86
Vested	(2,541)	$	19.74
Forfeited	(1,456)	$	17.85
Balance as of June 30, 2026	9,734	$	17.29

As of June 30, 2026, unrecognized compensation expense related to unvested RSUs and PSUs was $153.4 million. These costs are expected to be recognized over a weighted-average period of 2.1 years.


	Number of Options	Weighted- Average Exercise Price per Share		Weighted - Average remaining Contractual Life (Years)	Aggregate Intrinsic Value (1)
Balance as of December 31, 2025	2,049	$	27.42	5.73	$	7,321
Granted	—	$	—
Exercised	(9)	$	5.76
Forfeited	—	$	—
Balance as of June 30, 2026	2,040	$	27.52	5.23	$	4,928
Exercisable as of June 30, 2026	1,969	$	27.74	5.18	$	4,928
Vested as of June 30, 2026	1,969	$	27.74	5.18	$	4,928

(1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates.

As of June 30, 2026, aggregate unrecognized compensation expense related to unvested outstanding stock options was $0.9 million. These costs are expected to be recognized over a weighted-average period of 0.5 years.